80 FR 68880 - Northwest Medical Isotopes, LLC

NUCLEAR REGULATORY COMMISSION

Federal Register Volume 80, Issue 215 (November 6, 2015)

The U.S. Nuclear Regulatory Commission (NRC) has received and is making available the second and final part of a two-part application for a construction permit, submitted by Northwest Medical Isotopes, LLC (NWMI or the applicant). The applicant proposes to build a medical radioisotope facility located in Columbia, Missouri.

[Federal Register Volume 80, Number 215 (Friday, November 6, 2015)]
[Notices]
[Pages 68880-68881]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-28357]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 50-609; NRC-2013-0235]


Northwest Medical Isotopes, LLC

AGENCY: Nuclear Regulatory Commission.

ACTION: Construction permit application; receipt.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has received and 
is making available the second and final part of a two-part application 
for a

[[Page 68881]]

construction permit, submitted by Northwest Medical Isotopes, LLC (NWMI 
or the applicant). The applicant proposes to build a medical 
radioisotope facility located in Columbia, Missouri.

DATES: On July 20, 2015, the applicant filed the second and final part 
of a two-part application for a construction permit.

ADDRESSES: Please refer to Docket ID NRC-2013-0235 when contacting the 
NRC about the availability of information regarding this document. You 
may obtain publicly-available information related to this document 
using any of the following methods:
     Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2013-0235. Address 
questions about NRC dockets to Carol Gallagher; telephone: 301-415-
3463; email: [email protected]. For technical questions, contact 
the individual listed in the FOR FURTHER INFORMATION CONTACT section of 
this document.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209, 301-415-4737, or by email to [email protected]. The 
ADAMS accession number for each document referenced (if it is available 
in ADAMS) is provided the first time that a document is referenced.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.

FOR FURTHER INFORMATION CONTACT: Michael F. Balazik, Office of Nuclear 
Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC 
20555-0001; telephone: 301-415-2856; email: [email protected].

SUPPLEMENTARY INFORMATION: On July 20, 2015, NWMI filed with the NRC, 
pursuant to Section 103 of the Atomic Energy Act of 1954, as amended, 
and part 50 of title 10 of the Code of Federal Regulations (10 CFR), 
the second and final part of a two-part application for a construction 
permit for a medical radioisotope production facility in Columbia, 
Missouri (ADAMS Accession No. ML15086A262). The applicant is requesting 
a combined license in accordance with 10 CFR 50.31 and 10 CFR 50.32.
    An exemption from certain requirements of 10 CFR 2.101(a)(5) 
granted by the Commission on October 7, 2013 (ADAMS Accession No. 
ML13238A333 and 78 FR 63501), in response to a letter from NWMI dated 
August 9, 2013 (ADAMS Accession No. ML13227A295), allowed for NWMI to 
submit its construction permit application in two parts. Specifically, 
the exemption allowed NWMI to submit a portion of its construction 
permit application for a construction permit up to six months prior to 
submitting the remainder of the application regardless of whether or 
not an environmental impact statement or a supplement to an 
environmental impact statement is prepared during the review of its 
application. By letter dated November 7, 2014, NWMI submitted part one 
of its construction permit application to the NRC. By letter dated 
February 5, 2015 (ADAMS Accession No. ML15086A262, Package No. 
ML15086A261), NWMI withdrew and resubmitted part one of its 
construction permit application and included a discussion of connected 
actions in its environmental report in response to a January 23, 2015, 
letter from the NRC (ADAMS Accession No. ML14349A501). A notice of 
receipt and availability of part one of the construction permit 
application was previously published in the Federal Register on April 
21, 2015 (80 FR 22227). The first part of NWMI's construction permit 
application contained the following information:
     The description and safety assessment of the site required 
by 10 CFR 50.34(a)(1),
     the environmental report required by 10 CFR 50.30(f),
     the filing fee information required by 10 CFR 50.30(e) and 
10 CFR 170.21,
     the general information required by 10 CFR 50.33, and
     the agreement limiting access to classified information 
required by 10 CFR 50.37.
    The NRC staff published in the Federal Register on June 8, 2015 (80 
FR 32418), its determination that part one of NWMI's construction 
permit application is acceptable for docketing.
    The NWMI states that part two of its application for a construction 
permit contains the remainder of the preliminary safety analysis report 
required by 10 CFR 50.34(a).
    Subsequent Federal Register notices will address the acceptability 
of this part of the tendered construction permit application for 
docketing and provisions for public participation in the construction 
permit application review process.

    Dated at Rockville, Maryland, this day 28 of October, 2015.

    For the Nuclear Regulatory Commission.
Alexander Adams, Jr.,
Chief, Research and Test Reactors Licensing Branch, Division of Policy 
and Rulemaking, Office of Nuclear Reactor Regulation.
[FR Doc. 2015-28357 Filed 11-5-15; 8:45 am]
BILLING CODE 7590-01-P